|Articles|February 1, 2016
- Pharmaceutical Executive-02-01-2016
- Volume 36
- Issue 2
Pharmaceutical Executive, February 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 10 years ago
Life and Lipitor: Pfizer's Traci Medford-Rosowalmost 10 years ago
The Staying Power of Emerging Marketsalmost 10 years ago
Canada's Rx&D: Fresh Start for a New Eraalmost 10 years ago
Morgan Moments: A Closer Reading of the JP Morgan Investor Conferencealmost 10 years ago
Pharma dot-gov: A New Business Modelalmost 10 years ago
The Creative Impulse: Defending Pharma and Health DTCalmost 10 years ago
Securing Cipla’s Futurealmost 10 years ago
Country Report: South AfricaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Next-Gen CDMOs: Keeping Pace With Industry Change
2
Novo Nordisk Submits Higher-Dose Wegovy Injectable for FDA Approval with Priority Voucher
3
How Will FDA's Priority Review Program Impact Domestic Manufacturing?
4
Pharmaceutical Executive Daily: Novartis Cuts 550 Jobs
5
